Cargando…
Myelination in Multiple Sclerosis Lesions Is Associated with Regulation of Bone Morphogenetic Protein 4 and Its Antagonist Noggin
Remyelination is a central aspect of new multiple sclerosis (MS) therapies, in which one aims to alleviate disease symptoms by improving axonal protection. However, a central problem is mediators expressed in MS lesions that prevent effective remyelination. Bone morphogenetic protein4 (BMP4) inhibit...
Autores principales: | Harnisch, Kim, Teuber-Hanselmann, Sarah, Macha, Nicole, Mairinger, Fabian, Fritsche, Lena, Soub, Daniel, Meinl, Edgar, Junker, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337410/ https://www.ncbi.nlm.nih.gov/pubmed/30609838 http://dx.doi.org/10.3390/ijms20010154 |
Ejemplares similares
-
MicroRNA profiles of MS gray matter lesions identify modulators of the synaptic protein synaptotagmin‐7
por: Fritsche, Lena, et al.
Publicado: (2019) -
Expression of noggin, an antagonist of bone morphogenetic protein, in schwannoma: A possible mechanism
por: KANEKO, KEIKO, et al.
Publicado: (2014) -
MGMT-Methylation in Non-Neoplastic Diseases of the Central Nervous System
por: Teuber-Hanselmann, Sarah, et al.
Publicado: (2021) -
Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, chordin and DAN
por: Reddi, Hari A
Publicado: (2001) -
The Role of the BMP Signaling Antagonist Noggin in the Development of Prostate Cancer Osteolytic Bone Metastasis
por: Secondini, Chiara, et al.
Publicado: (2011)